Leading the Way in Russian Law
 


NEWS

more news

PUBLICATIONS

more publications

EVENTS

more events

RECENT DEALS

Legal support of the fund established by inheritors of the famous Tove Jansson in monitoring online and offline infringements and protecting their copyrights to Moomin characters in Russia
more recent deals


  • Nikita Ayrapetov,
    Junior Associate

RSS  RSS Feed to Legal Updates

NEWS & PRESS RELEASES  |  ARTICLES  |  BOOKS  |  LEGAL UPDATES  |  MEDIA ROOM  |  RSS FEEDS  |  SUBSCRIBE


Roszdravnadzor has defined criteria for blocking websites selling medicines


 
4 September 2020 the Russian Ministry of Justice registered the Order No. 5527 of Roszdravnadzor dd. 29 June 2020, approving criteria for evaluating the information, publication of which may result in a website inclusion in the register of prohibited websites and its blocking. The Federal Service for Surveillance in Healthcare (Roszdravnadzor) renders such a decision.
 
A website may be blocked if the published information meets one or several criteria below:
 
  • Counterfeit and poor-quality medicines are offered for sale
  • Unregistered medicines are offered for sale
  • Medicines not approved by the Rules on online sales and delivery of medicines are offered for online sale
  • Online pharmacy uses domain names and/or page indexes on websites not listed in the online sales authorization
  • Medicines limited or prohibited for sale, as well as an online sale, are offered for sale
 
Roszdravnadzor may block the website if a person offering medicines for sale does not have a pharmaceutical license and, if applicable, authorization for online sales of medicines, or if he or she publishes the information forming among audience a positive image of persons engaged in the unauthorized online sale of medicines (excluding artistic works describing the information justified by their genre).
 
Roszdravnadzor approval of the abovementioned criteria is a logical continuation of the Rules on online sale and delivery of medicines enacted in May 2020. Such restrictions shall reduce the number of unfair sellers who do not have the authorization to sell medicines. However, a question of whether the criteria will be applied effectively remains open. 
 


back to Legal Updates   |   print page



TOP M&A
Legal Advisor
in Russia


Recommended in
All Key Practice Areas


Recommended Firm
for Dispute Resolution
in Russia


Best Life Sciences
Practice in Russia


Best Life Sciences practice,
recommended in corporate 

and M&A, dispute resolution 
in Russia


The Most Visible
Russian Law Firm


Recommended in
Key Practice Areas

Open Partnership: 
an inside look